Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Nalibao Pills (脑力宝丸) is a traditional Chinese medicine (TCM) product manufactured by Jiangxi Wannianqing Pharmaceutical. It is primarily indicated for the treatment of neurasthenia, characterized by symptoms such as insomnia, forgetfulness, dizziness, and mental fatigue. The formulation is a complex mixture of traditional herbs, typically including Polygalae Radix (Yuan Zhi), Acori Tatarinowii Rhizoma (Shi Chang Pu), Schisandrae Chinensis Fructus (Wu Wei Zi), Poria (Fu Ling), and Rehmanniae Radix (Di Huang). These components are traditionally recognized in Chinese medicine for their ability to nourish the kidneys, tonify the heart, and soothe the nerves. As a marketed TCM product in China, it is administered orally in pill form and is used to improve cognitive function and sleep quality in patients suffering from mental exhaustion.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on naolibao wan.